Scilex Holding (SCLX) Gains from Investment Securities (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Gains from Investment Securities of $324000.0 for Q1 2026, up 5300.0% year-over-year from $6000.0 in Q1 2025, and down 98.31% on a QoQ basis from $19.2 million in Q4 2025.

Scilex Holding (SCLX) Gains from Investment Securities (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Gains from Investment Securities for 7 consecutive years, with $324000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gains from Investment Securities rose 5300.0% year-over-year to $324000.0; the TTM figure through Mar 2026 stood at $19.5 million (up 325600.0% YoY), while the FY2025 annual figure was $1.5 million, up 146203.5% from the prior year.
  • Gains from Investment Securities came in at $324000.0 for Q1 2026 at Scilex Holding, down from $19.2 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $19.2 million in Q4 2025, with the low at -$2.5 million in Q2 2022.
  • Average Gains from Investment Securities over 5 years is $1.1 million, with a median of $30000.0 recorded in 2024.
  • Across the five-year window, Gains from Investment Securities slumped 3800.0% in 2022 and jumped 64160.0% in 2025, its largest moves.
  • Year by year, Gains from Investment Securities stood at $685000.0 in 2022, then tumbled by 107.45% to -$51000.0 in 2023, then jumped by 41.18% to -$30000.0 in 2024, then surged by 64160.0% to $19.2 million in 2025, then slumped by 98.31% to $324000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered $324000.0, $19.2 million, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10,000.00
Mar 31, 2026 10,000.00
Dec 31, 2025 19.22 Mn
Dec 31, 2025 19.22 Mn
Sep 30, 2025 30,000.00
Sep 30, 2025 30,000.00
Jun 30, 2025 19,000.00
Jun 30, 2025 19,000.00
Mar 31, 2025 6,000.00
Mar 31, 2025 6,000.00
Dec 31, 2024 -30,000.00
Dec 31, 2024 -30,000.00
Sep 30, 2024 476,000.00
Sep 30, 2024 476,000.00
Jun 30, 2024 121,000.00
Jun 30, 2024 121,000.00
Mar 31, 2024 33,267.00
Mar 31, 2024 33,267.00
Dec 31, 2023 -51,000.00
Dec 31, 2023 -51,000.00